National Comprehensive Cancer Network

About NCCN

NCCN Launches Free NCCN Guidelines Mobile App for iPhone and Android


The National Comprehensive Cancer Network® (NCCN®) goes mobile with the launch of free NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) apps for iPhone and Android. These apps provide registered users of NCCN.org mobile access to the NCCN Guidelines™.


June 16, 2010

FORT WASHINGTON, PA — The National Comprehensive Cancer Network® (NCCN®) improves access to the latest information on cancer treatment recommendations with the launch of the NCCN Guidelines App for iPhone and Android. These new apps are free and enable registered users on NCCN.org to view the NCCN Guidelines from their smartphone. The NCCN Guidelines apps are among the first free mobile applications available that are designed to assist in the selection of treatment for patients with cancer.

“Physicians and other health care professionals are adopting mobile eHealth technology at an accelerating rate,” said William T. McGivney, PhD, Chief Executive Officer, NCCN. “We are pleased to be able to offer providers improved access to the critical information found in the NCCN Guidelines at or near the point of patient care or anywhere through these new mobile applications.”

NCCN Guidelines apps are free to download through the iTunes store and Android Market and can be found easily by searching for “NCCN” in the respective marketplace. In addition, the Android Market Bar Code for the NCCN Guidelines app is available on-line at NCCN.org. To view the NCCN Guidelines through the apps, individuals must be a registered user on NCCN.org. There is no fee to become a registered user on NCCN.org and to view the NCCN Guidelines.

NCCN mobile apps provide access to the complete library of NCCN Guidelines, which cover 97 percent of all patients with cancer. NCCN Guidelines are the standard for cancer care in the United States and internationally. These guidelines are updated on a continual basis by an explicit review of evidence integrated with expert medical judgment and recommendations by multidisciplinary panels at NCCN Member Institutions. Users of the NCCN Guidelines apps have the ability to view all components of the NCCN Guidelines, including but not limited to, the algorithms, discussion section, and list of updates from the previous year’s version.

“Mobile devices have quickly become a preferred vehicle for physicians to access clinical information due to their ease of use and inherent portability,” said Thomas D’Amico, MD, of Duke Comprehensive Cancer Center and chairman of the NCCN Board of Directors. “Being able to access the NCCN Guidelines at the point of care and elsewhere is invaluable for clinicians striving to keep up-to-date with the latest treatment recommendations that can benefit their patients.”

According to a May 2010 report from Manhattan Research, the percentage of physicians now using smartphones in the United States is 72 percent. The same report predicts that about 81 percent of physicians will use smartphones by 2012.

For additional information, visit NCCN.org/mobile.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 25 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.

The NCCN Member Institutions are:

  • Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center
  • City of Hope Comprehensive Cancer Center
  • Dana-Farber/Brigham and Women's Cancer Center
    Massachusetts General Hospital Cancer Center
  • Duke Cancer Institute
  • Fox Chase Cancer Center
  • Huntsman Cancer Institute at the University of Utah
  • Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Mayo Clinic Cancer Center
  • Memorial Sloan-Kettering Cancer Center
  • Moffitt Cancer Center
  • The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
  • Roswell Park Cancer Institute
  • Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
  • Stanford Cancer Institute
  • University of Alabama at Birmingham Comprehensive Cancer Center
  • UC San Diego Moores Cancer Center
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of Colorado Cancer Center
  • University of Michigan Comprehensive Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • Vanderbilt-Ingram Cancer Center
  • Yale Cancer Center/Smilow Cancer Hospital